Michael J. Yost

Cardiovascular tissue engineering I. Perfusion bioreactors: a review.

Novel therapies for scar reduction and regenerative healing of skin wounds.

Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells.

A model system for primary abdominal closures.

Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissues.

A Connexin43 Mimetic Peptide Promotes Regenerative Healing and Improves Mechanical Properties in Skin and Heart.

Scaffold-free tissue engineering: organization of the tissue cytoskeleton and its effects on tissue shape.

3D printing facilitated scaffold-free tissue unit fabrication.

The impact of flow-induced forces on the morphogenesis of the outflow tract.

Engineering alginate as bioink for bioprinting.

Biomedical implant capsule formation: lessons learned and the road ahead.

Predicting academic performance in surgical training.

Implanted scaffold-free prevascularized constructs promote tissue repair.

Inhibition of connexin 43 hemichannel-mediated ATP release attenuates early inflammation during the foreign body response.

Connexin-Based Therapeutics and Tissue Engineering Approaches to the Amelioration of Chronic Pancreatitis and Type I Diabetes: Construction and Characterization of a Novel Prevascularized Bioartificial Pancreas.

Mechanism of action of the anti-inflammatory connexin43 mimetic peptide JM2.

Eliminating glutaraldehyde from crosslinked collagen films using supercritical CO.

Constitutive modeling of compressible type-I collagen hydrogels.